Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;120:318-325
Published online before print July 13, 2009, doi: 10.1161/CIRCULATIONAHA.109.873380
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
120/4/318    most recent
CIRCULATIONAHA.109.873380v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lu, Z.
Right arrow Articles by Lin, R. Z.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, Z.
Right arrow Articles by Lin, R. Z.
Related Collections
Right arrow Contractile function
Right arrow Animal models of human disease
Right arrow Ion channels/membrane transport
Right arrowRelated Article

(Circulation. 2009;120:318-325.)
© 2009 American Heart Association, Inc.


Molecular Cardiology

Loss of Cardiac Phosphoinositide 3-Kinase p110{alpha} Results in Contractile Dysfunction

Zhongju Lu, PhD*; Ya-Ping Jiang, MD*; Wei Wang, PhD; Xin-Hua Xu, MD; Richard T. Mathias, PhD; Emilia Entcheva, PhD; Lisa M. Ballou, PhD; Ira S. Cohen, MD, PhD; Richard Z. Lin, MD

From the Department of Physiology and Biophysics and Institute of Molecular Cardiology (Z.L., W.W., R.T.M., E.E., I.S.C., R.Z.L.) and Department of Medicine (Y.P.J., L.M.B., R.Z.L.), Stony Brook University, Stony Brook, NY; Department of Cardiac Surgery, Central South University, Changsha, China (X.H.X.); and Department of Veterans Affairs Medical Center, Northport, NY (R.Z.L.).

Correspondence to Dr Richard Z. Lin, Division of Hematology/Oncology, HSC T15–045, Stony Brook University, Stony Brook, NY 11794–8151. E-mail richard.lin{at}sunysb.edu

Received August 14, 2009; accepted May 5, 2009.

Background— Phosphoinositide 3-kinase (PI3K) p110{alpha} plays a key role in insulin action and tumorigenesis. Myocyte contraction is initiated by an inward Ca2+ current (ICa,L) through the voltage-dependent L-type Ca2+ channel (LTCC). The aim of this study was to evaluate whether p110{alpha} also controls cardiac contractility by regulating the LTCC.

Methods and Results— Genetic ablation of p110{alpha} (also known as Pik3ca), but not p110β (also known as Pik3cb), in cardiac myocytes of adult mice reduced ICa,L and blocked insulin signaling in the heart. p110{alpha}-null myocytes had a reduced number of LTCCs on the cell surface and a contractile defect that decreased cardiac function in vivo. Similarly, pharmacological inhibition of p110{alpha} decreased ICa,L and contractility in canine myocytes. Inhibition of p110β did not reduce ICa,L.

Conclusions— PI3K p110{alpha} but not p110β regulates the LTCC in cardiac myocytes. Decreased signaling to p110{alpha} reduces the number of LTCCs on the cell surface and thus attenuates ICa,L and contractility.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 120: 267-268. [Extract] [Full Text]